Mark J. Tarr - 18 Feb 2026 Form 4 Insider Report for Encompass Health Corp (EHC)

Role
President & CEO, Director
Signature
/s/ Patrick Darby, attorney-in-fact for Mark J. Tarr
Issuer symbol
EHC
Transactions as of
18 Feb 2026
Net transactions value
$0
Form type
4
Filing time
20 Feb 2026, 15:41:51 UTC
Previous filing
12 Feb 2026
Next filing
23 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tarr Mark J President & CEO, Director 9001 LIBERTY PARKWAY, BIRMINGHAM /s/ Patrick Darby, attorney-in-fact for Mark J. Tarr 20 Feb 2026 0001304057

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EHC Encompass Health Common Stock Award $0 +100,946 +27% $0.000000 478,016 18 Feb 2026 Direct F1
transaction EHC Encompass Health Common Stock Award $0 +12,796 +2.7% $0.000000 490,812 19 Feb 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This issuance of restricted stock is the result of the satisfaction of performance criteria set out in the terms of a performance share unit award made on February 23, 2023.
F2 Annual award of restricted stock pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.